LAG3 and cancer: In addition, newly discovered immune checkpoints (ICs) such as lymphocyte-activation gene 3 (LAG3), T cell immunoglobulin and mucin domain 3 (Tim-3), as well as T cell immunoreceptor with immunoglobulin and ITIM domain (TIGIT) are also attracting attention in the field of cancer immunotherapy (3–6).